Skip to main content
Home
    • en
    • fr

  • Search form

Main menu

  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux

  • Responsibility
    • Our ambition
    • Health
    • Planet
    • Healthcare ecosystem
    • Employees
    • Extended Company
    • SantéRESISTANCE TO ANTIBIOTICS
    • PlanèteCOVID-19 EXCEPTIONAL DONATIONS
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity
    • Resource Center
    • CLINICAL SOLUTIONS
    • INDUSTRY SOLUTIONS
  • Expertise
    • The importance of diagnostics
      • Clinical diagnostics
      • Industrial Microbiological Control
    • Clinical applications
      • Infectious diseases
      • COVID-19
      • Antimicrobial resistance and Healthcare-associated infections
      • Cardiovascular Emergencies
      • Personalized medicine
    • Industrial applications
      • Agri-food sector
      • Biopharma & cosmetics sectors
    • Our technologies, systems and services
      • Microbiology
      • Molecular Biology
      • Immunoassays
      • Services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
      • Webinars
      • Educational Materials
      • External Resources
    • Sepsis / Bloodstream Infections
      • Webinars
      • Educational Tutorials
      • Educational Materials
      • External Resources
    • COVID-19
      • Webinars
      • Educational Materials
    • Acute Kidney Injury
      • Webinars & Symposiums
      • Educational Materials
      • External Resources
    • Cardiac Emergencies
      • Educational Tutorials
      • Educational Materials
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
    • UNIVERSAL REGISTRATION DOCUMENT
    • CORPORATE SOCIAL RESPONSIBILITY
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
    • In the fight against Antimicrobial Resistance, bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe
    • PRESS CONTACTS
     
  • Careers
    • Joining bioMérieux
      • Corporate culture
      • Public health mission
      • International presence
      • Professional development
      • Diversity and inclusion
      • Well-being at work
      • Compensation and benefits
    • Job Profiles
      • R&D
      • Manufacturing
      • Supply Chain
      • Information Systems
      • Quality
      • Business
      • Support Functions
      • Medical Affairs
      • HSE
      • Clinical Affairs and Regulatory Affairs
  • Contact us
Home
  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux
  • Responsibility
    • Our ambition
    • Health
    • Planet
    • Healthcare ecosystem
    • Employees
    • Extended Company
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity
    • Resource Center
  • Expertise
    • The importance of diagnostics
    • Clinical applications
    • Industrial applications
    • Our technologies, systems and services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
    • Sepsis / Bloodstream Infections
    • COVID-19
    • Acute Kidney Injury
    • Cardiac Emergencies
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
  • Careers
    • Joining bioMérieux
    • Job Profiles
  • Contact us
    • Investor Relations
    • Press Contacts
    • en
    • fr

  • Search form

You are here

Printer-friendly version
  • Home
  • Investors
  • Governance
  • Status
Investors
  • The bioMérieux Share
    • Stock Market Information
    • Historic Chart
    • Analysts Coverage
    • Analysts Consensus
  • Publications
    • Calendar
    • Press Releases
    • Presentations
    • Annual Reports
    • Universal Registration Documents
  • Regulated Information
  • Governance
    • Regulated Agreements
    • Status
    • Board Charter
  • Shareholder area
    • General Shareholders' Meeting
    • Participating In The General Shareholder's Meeting
    • Dividends
    • Crossing the Thresholds

Status

Press Release
  • June 29, 2021 In the fight against Antimicrobial Resistance, bioMérieux and Spec...
  • June 24, 2021 bioMérieux launches EPISEQ® SARS-COV-2, a cloud-based software ap...
  • May 07, 2021 bioMérieux announces the CE marking of the new generation semi-qua...
  • April 30, 2021 bioMérieux announces CE-marking of the new MALDI-TOF mass spectrom...
Annual Report

Clinical Solutions

To discover all of our products for Clinical applications, please visit bioMérieux Diagnostics website.

Industry Solutions

To discover all of our products for industrial microbiological control, please visit our bioMérieux Industry website.

Download the bioMérieux SA Articles of Association

Updated June 15th, 2021

Pioneering diagnostics
  • Legal Notice
  • Privacy
  • Cookie Policy
  • Contact
  • Copyright 2021 bioMérieux SA
  • biomerieux.com
  • bioMérieux Worldwide >
    Discover all our locations
    Asia
    • China (Website)
    • India (Website)
    • Indonesia (website)
    • Japan (Website)
    • Korea
    • Malaysia (website)
    • Philippines (website)
    • Singapore (Website)
    • Thailand (website)
    • Vietnam (website)
    Europe, Middle East, Africa
    • Algeria
    • Austria (Website)
    • Belgium
    • Czech Republic (Website)
    • Denmark (Website)
    • Finland (Website)
    • France (Website)
    • Germany (Website)
    • Greece
    • Hungary (Website)
    • Italy (Website)
    • Ivory Coast
    • Netherlands
    • Norway (Website)
    • Poland (Website)
    • Portugal (Website)
    • Russia (Website)
    • Serbia
    • South Africa (Website)
    • Spain (Website)
    • Sweden (Website)
    • Switzerland (Website)
    • Turkey (Website)
    • United Arab Emirates
    • United Kingdom (Website)
    North America
    • Canada (Website)
    • United States (Website)
    Oceania
    • Australia (Website)
    • New Zealand (Website)
    South America
    • Argentina (Website)
    • Brazil (Website)
    • Chile (Website)
    • Colombia (Website)
    • Mexico (Website)
  • Our Specific Websites >
    • Antimicrobial Resistance Website
    • BioFire Diagnostics
    • bioMérieux Clinical Diagnostics
    • bioMérieux Industry
    • bioMérieux Investors
    • bioMérieux Recruitment
    • bioMérieux Culture Media
  • Our communities >
    • mybiomerieux.com